Entre as marcas dos nossos mais de 25 parceiros, destaca-se a TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Termina em 31 de dez.( faltam 8 dias )
Olamkicept
CAS:Olamkicept (FE-301) is a soluble gp130-Fc-fusion protein that inhibits interleukin 6 (IL-6) trans signaling.Pureza:98.2% (SDS-PAGE); 98.8% (SEC-HPLC) - 99.3% (SDS-PAGE); 97.6% (SEC-HPLC)Cor e Forma:LiquidMBP146-78
CAS:<p>MBP146-78 is a potent and selective cGMP inhibitor dependent protein kinases.</p>Fórmula:C21H22FN3Pureza:99.33%Cor e Forma:SolidPeso molecular:335.42Notum-IN-1
CAS:Notum-IN-1 is an orally administered, selective, and brain-penetrating compound that acts as an inhibitor of Notum.Fórmula:C9H7Cl2N3OCor e Forma:SolidPeso molecular:244.08RX 801077
CAS:RX 801077 is a selective I2R agonist, Ki of 70.1 nM, with anti-inflammatory and neuroprotective properties for TBI research.Fórmula:C11H10N2OCor e Forma:SolidPeso molecular:186.21PD 168568
CAS:PD 168568: Oral DRD4 antagonist, selective over D2/D3, K_i - 8.8 nM. Used in GBM research.Fórmula:C22H27N3OCor e Forma:SolidPeso molecular:349.47Gepefrine
CAS:Gepefrine为具口服活性的升压剂及拟交感神经作用剂，能有效改善动脉压早期直立性失调。Fórmula:C9H13NOCor e Forma:SolidPeso molecular:151.21Crisnatol
CAS:<p>Crisnatol (BWA770U) is an oral anticancer DNA intercalator, toxic to breast cancer cells, not skin fibroblasts.</p>Fórmula:C23H23NO2Cor e Forma:SolidPeso molecular:345.43Epitizide
CAS:Epitizide, a benzothiadiazine, commonly found in combination Triamterene , is used to produce diuresis [1] .Fórmula:C10H11ClF3N3O4S3Cor e Forma:SolidPeso molecular:425.86Theliatinib
CAS:<p>Theliatinib: potent, selective EGFR inhibitor, anti-tumor; Ki=0.05 nM (EGFR), IC50=3 nM (EGFR), 22 nM (T790M/L858R).</p>Fórmula:C25H26N6O2Pureza:99.67%Cor e Forma:SolidPeso molecular:442.51RO5461111
CAS:RO5461111: Oral Cathepsin S inhibitor, IC50 of 0.4 nM (human) & 0.5 nM (mouse), reduces T/B cell activation, treats lung inflammation & lupus nephritis.Fórmula:C27H24F6N4O4SCor e Forma:SolidPeso molecular:614.56CASK-IN-1
CAS:CASK-IN-1 is a highly potent and selective CASK inhibitor with a K d value of 0.022 μM.Fórmula:C24H30Br2N6O3Cor e Forma:SolidPeso molecular:610.34LDHA-IN-5
CAS:LDHA-IN-5 is a novel and potent inhibitor targeting both glycolate oxidase (GO) and lactate dehydrogenase A (LDHA), designed for the treatment of primaryFórmula:C27H22FN7O6S3Cor e Forma:SolidPeso molecular:655.7NS5A-IN-3
CAS:<p>NS5A-IN-3 is a potent NS5A inhibitor with high efficacy against HCV 1b, good activity on 3a, and strong metabolic stability; superior to daclatasvir.</p>Fórmula:C44H44N6O8Pureza:98%Cor e Forma:SolidPeso molecular:784.86AMPK-IN-1
CAS:AMPK-IN-1 is an activator of the AMP-activated protein kinase (AMPK) enzyme, specifically targeting the α2β2γ1 isoform with an EC50 of 551 nM.Fórmula:C24H18ClN3O3Cor e Forma:SolidPeso molecular:431.87OTS193320
CAS:OTS193320, an imidazo[1,2-a]pyridine, inhibits SUV39H2, reduces H3K9me3, and induces apoptosis in breast cancer; enhances DOX effects.Fórmula:C28H30ClN5O4Cor e Forma:SolidPeso molecular:536.02SH-BC-893
CAS:SH-BC-893: Oral anti-cancer sphingolipid analog, prevents ceramide-related mitochondrial issues, and tackles diet-related obesity.Fórmula:C19H32ClNOCor e Forma:SolidPeso molecular:325.92Artonin E
CAS:Artonin E, a prenylated flavonoid, induces apoptosis and S-phase arrest, disrupting the mitochondrial pathway for cancer research.Fórmula:C25H24O7Cor e Forma:SolidPeso molecular:436.45Mps1-IN-4
CAS:Mps1-IN-4 is a compound that selectively inhibits Monopolar spindle 1 (Mps1), exhibiting antiproliferative properties useful in cancer research.Fórmula:C26H31F3N6O2Cor e Forma:SolidPeso molecular:516.56BCI-215
CAS:<p>BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling</p>Fórmula:C22H22BrNOPureza:99.812%Cor e Forma:SolidPeso molecular:396.32UT-B-IN-1
CAS:<p>UT-B-IN-1: reversible UT-B inhibitor, IC50: 10 nM (human), 25 nM (mouse), low toxicity, diuretic research tool.</p>Fórmula:C20H17N5O2S3Cor e Forma:SolidPeso molecular:455.58RR-RJW100
RR-RJW100: potent LRH-1 & SF-1 agonist; studies metabolic disorders, diabetes, liver disease, IBD.Fórmula:C28H34OCor e Forma:SolidPeso molecular:386.57Ciramadol
CAS:Ciramadol (WY 15705) is a potent analgesic with dual narcotic effects, used in postoperative pain research.Fórmula:C15H23NO2Cor e Forma:SolidPeso molecular:249.35USP7-797
CAS:USP7-797 is a selective non-covalent active site USP7 inhibitor, inhibiting USP7 and ubiquitin binding, with anti-tumor, oral and high efficiency properties.Fórmula:C27H28ClN3O3SPureza:95.90%Cor e Forma:SolidPeso molecular:510.05GPX4-IN-2
CAS:GPX4-IN-2 is a potent inhibitor of GPX4, exhibiting antiproliferative activity. It holds potential for cancer research applications.Fórmula:C30H40N2OCor e Forma:SolidPeso molecular:444.65gTPA2-OMe
gTPA2-OMe is a potential hole transport layer candidate for perovskite solar cells (PSCs).Fórmula:C32H33N7O2Cor e Forma:SolidPeso molecular:547.65DC-BPi-11
CAS:DC-BPi-11 inhibits BPTF at IC50 698 nM and significantly reduces leukemia cell growth.Fórmula:C20H23N5O2SCor e Forma:SolidPeso molecular:397.49Chelidonine hydrochloride
CAS:Chelidonine hydrochloride is one of the alkaloids of Chelidonium majus, which has broad pharmacological activitiesFórmula:C20H20ClNO5Pureza:>99.99%Cor e Forma:SolidPeso molecular:389.83PDE5-IN-4
CAS:PDE5-IN-4, a phosphodiesterase 5 (PDE5) inhibitor, is utilized in research concerning acute myocardial infarction and reperfusion-related damage,Fórmula:C21H27N5O5SCor e Forma:SolidPeso molecular:461.53NSD3-IN-1
CAS:NSD3-IN-1, a histone methyltransferase NSD3 inhibitor, demonstrates an IC50 of 28.58 μM.Fórmula:C13H13N5OSCor e Forma:SolidPeso molecular:287.34NSD3-IN-2
CAS:NSD3-IN-2: Potent NSD3 inhibitor, IC50 17.97μM, halts NSCLC growth (H460, H1299, H1650) with anticancer effects.Fórmula:C17H15N5OSCor e Forma:SolidPeso molecular:337.4NSD3-IN-3
CAS:"NSD3-IN-3, a potent anticancer agent, inhibits NSD3 (IC50: 1.86 μM) and hampers H460 lung cancer cell growth."Fórmula:C15H17N5O2SCor e Forma:SolidPeso molecular:331.39AChE-IN-9
AChE-IN-9: Tacrine-β-glucose glycoconjugate; IC50 0.4μM; reduced hepatotoxicity; Alzheimer's research.Fórmula:C30H35N5O9Cor e Forma:SolidPeso molecular:609.63EZH2-IN-7
CAS:<p>EZH2-IN-7 inhibits EZH2, reducing H3K27me3 and tumor growth (e.g., breast, prostate cancer, leukemia). Potential in cancer research.</p>Fórmula:C31H37D2N5O3SCor e Forma:SolidPeso molecular:563.75PIM1-IN-4
CAS:<p>PIM1-IN-4: strong PIM1 inhibitor, also blocks SGK-1, PKA, CaMK-1, GSK3β, MSK1; promising for cancer studies.</p>Fórmula:C27H25BrCl2CuN6OPureza:98%Cor e Forma:SolidPeso molecular:663.88RET-IN-13
CAS:RET-IN-13: potent quinoline RET inhibitor; IC50 = 0.5 nM (WT), 0.9 nM (V804M); potential for RET-related tumor/intestinal disease research.Fórmula:C32H33F4N5O3Cor e Forma:SolidPeso molecular:611.63HBV-IN-15
CAS:HBV-IN-15, a flavone derivative, is a potent cccDNA inhibitor, potentially aiding HBV research.Fórmula:C24H23ClO6Cor e Forma:SolidPeso molecular:442.89JAK-IN-17
"JAK-IN-17: Potent JAK inhibitor for studying ocular, skin, and respiratory diseases."Fórmula:C33H38F2N6O8Cor e Forma:SolidPeso molecular:684.69EIDD-2749
CAS:<p>EIDD-2749 (4'-Fluorouridine), an oral drug, inhibits RdRp, halts RSV/SARS-CoV-2 replication, and fights HCV/LCMV.</p>Fórmula:C9H11FN2O6Pureza:97.39%Cor e Forma:SolidPeso molecular:262.19TrxR-IN-4
CAS:TrxR-IN-4, a strong TrxR inhibitor, induces ERS, apoptosis in HepG2 cells, reduces liver damage by lowering TrxR and inflammation.Fórmula:C28H20AuF8N2O2PCor e Forma:SolidPeso molecular:796.4Akt1-IN-1
Akt1-IN-1: Potent, selective Akt1 inhibitor, IC50 18.79 nM, non-teratogenic/hepatotoxic/cardiotoxic, useful in cancer research.Fórmula:C31H34FN5O5S2Cor e Forma:SolidPeso molecular:639.76RET-IN-16
CAS:RET-IN-16: Selective RET inhibitor, IC50s 3.98-15.05 nM for various RET mutations; anticancer properties.Fórmula:C31H29F3N8O2Cor e Forma:SolidPeso molecular:602.61USP7-IN-9
USP7-IN-9 is a potent USP7 inhibitor (IC50 = 40.8 nM), induces apoptosis, arrests RS4;11 cells, and modulates key oncoproteins.Fórmula:C32H33ClF6N6O8Cor e Forma:SolidPeso molecular:779.086H05 (TFA)
CAS:6H05 TFA (6H05 trifluoroacetate) is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.Fórmula:C22H31ClF3N3O4S3Pureza:98.83%Cor e Forma:SolidPeso molecular:590.14C5aR-IN-1
CAS:C5aR-IN-1, a potent C5aR inhibitor, may aid in researching autoimmune and inflammatory diseases.Fórmula:C36H39F4N3O2Cor e Forma:SolidPeso molecular:621.71C5aR-IN-3
CAS:C5aR-IN-3, a potent C5aR inhibitor, may treat autoimmune and inflammatory diseases.Fórmula:C36H40FN5O3Cor e Forma:SolidPeso molecular:609.73L2H2-6OTD
CAS:L2H2-6OTD is a telomerase inhibitor with G-quadruplex loops; IC50: 15 nM.Fórmula:C30H30N10O8Cor e Forma:SolidPeso molecular:658.62Tolindate
CAS:Tolindate, a potent PXR agonist, demonstrates antifungal activity and possesses an EC50 value of 8.3 µM.Fórmula:C18H19NOSCor e Forma:SolidPeso molecular:297.41NVS-MALT1
CAS:<p>NVS-MALT1 is an allosteric inhibitor of MALT1 [1].</p>Fórmula:C24H27ClF3N5O4SCor e Forma:SolidPeso molecular:574.02VU6036720
<p>VU6036720 is a potent and selective inhibitor of the isomeric Kir4.1/5.1.VU6036720 inhibits Kir4.1/5.1 activity by decreasing the channel open-circuit</p>Fórmula:C20H22ClFN4O2SPureza:98.1%Cor e Forma:SoildPeso molecular:436.93hRSV-IN-1
CAS:<p>hRSV-IN-1 is an inhibitor of respiratory syncytial virus (hRSV) .</p>Fórmula:C24H25N5O3SCor e Forma:SolidPeso molecular:463.55
